Simulations Plus, Inc. (SLP)
NASDAQ: SLP · Real-Time Price · USD
15.60
+0.34 (2.23%)
At close: Oct 15, 2025, 4:00 PM EDT
15.30
-0.30 (-1.92%)
After-hours: Oct 15, 2025, 4:13 PM EDT
Simulations Plus Revenue
Simulations Plus had revenue of $20.36M in the quarter ending May 31, 2025, with 9.81% growth. This brings the company's revenue in the last twelve months to $80.38M, up 20.01% year-over-year. In the fiscal year ending August 31, 2024, Simulations Plus had annual revenue of $70.01M with 17.52% growth.
Revenue (ttm)
$80.38M
Revenue Growth
+20.01%
P/S Ratio
3.81
Revenue / Employee
$325,437
Employees
247
Market Cap
313.98M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2024 | 70.01M | 10.44M | 17.52% |
| Aug 31, 2023 | 59.58M | 5.67M | 10.52% |
| Aug 31, 2022 | 53.91M | 7.44M | 16.01% |
| Aug 31, 2021 | 46.47M | 4.88M | 11.73% |
| Aug 31, 2020 | 41.59M | 7.62M | 22.43% |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
SLP News
- 5 days ago - SLP SECURITIES NOTICE: Simulations Plus, Inc. Securities Fraud Investigation is Pending – Contact BFA Law if You Lost Money - GlobeNewsWire
- 7 days ago - SLP FRAUD NOTICE: Simulations Plus, Inc. Hit with Securities Fraud Investigation Due to Impairment Charges -- Contact BFA Law if You Suffered Losses - GlobeNewsWire
- 9 days ago - SLP SHAREHOLDER NOTICE: Simulations Plus, Inc. Investigated for Securities Fraud after 26% Stock Drop – Contact BFA Law - GlobeNewsWire
- 14 days ago - Johnson Fistel Investigates Simulations Plus Following Reports of Financial and Internal Control Issues - GlobeNewsWire
- 20 days ago - Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairment and Auditor Firing-- Hagens Berman - GlobeNewsWire
- 23 days ago - SLP SECURITIES NEWS: Why did Simulations Plus, Inc. Stock Drop 26%? Investors with Losses Reminded to Contact BFA Law - GlobeNewsWire
- 23 days ago - The Bottom Fishing Club - Simulations Plus: Huge Potential In AI Drug Discovery - Seeking Alpha
- 4 weeks ago - SLP SECURITIES NOTICE: Did Simulations Plus, Inc. Mislead Investors? Contact BFA Law if You Lost Money on Your Investment - GlobeNewsWire